Fifth Third Wealth Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$298K Sell
3,771
-8
-0.2% -$680 0.01% 714
2026
Q1
$326K Sell
3,779
-119
-3% -$10.7K 0.01% 564
2025
Q4
$340K Buy
3,898
+291
+8% +$22.1K 0.01% 527
2025
Q3
$207K Sell
3,607
-37
-1% -$2.13K 0.01% 734
2025
Q2
$215K Sell
3,644
-132
-3% -$8.53K 0.01% 682
2025
Q1
$276K Buy
3,776
+100
+3% +$8.26K 0.01% 523
2024
Q4
$304K Hold
3,676
0.02% 480
2024
Q3
$263K Buy
3,676
+40
+1% +$2.82K 0.02% 529
2024
Q2
$249K Buy
+3,636
New +$217K 0.02% 503

Other funds holding GMED

Fifth Third Wealth Advisors's GMED Position: Q2 2026 in Review

Fifth Third Wealth Advisors reduced its Globus Medical (GMED) stake by 0.21% in Q2 2026, selling an estimated $680 and leaving 3,771 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #714.

Fifth Third Wealth Advisors first reported a position in GMED in Q2 2024 and has held it in 9 quarters since. The position peaked at $340K in Q4 2025. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Fifth Third Wealth Advisors held 3,771 shares of Globus Medical worth $298K as of Q2 2026.
  • Fifth Third Wealth Advisors sold 8 Globus Medical shares in Q2 2026, an estimated $680.
  • Globus Medical made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #714 holding.
  • Fifth Third Wealth Advisors first reported a position in Globus Medical in Q2 2024 and has held it in 9 quarters since.
  • Fifth Third Wealth Advisors's Globus Medical position peaked at $340K in Q4 2025.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.